Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | VHL |
Variant | Y112N |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | VHL Y112N lies within the CCT complex-binding region of the Vhl protein (UniProt.org). Y112N confers a loss of function to the Vhl protein as demonstrated by reduced stability of the Vhl-Elongin B/C complex (PMID: 16261165), decreased Hif1a ubiquitination in in vitro assays (PMID: 16261165, PMID: 16407835), elevated Hif2a, Glut1, and cyclin D1 expression in normoxic conditions (PMID: 16407835, PMID: 17526729), increased cell proliferation in low serum conditions in culture (PMID: 17526729), and promotion of tumor formation in animal models (PMID: 17526729). |
Associated Drug Resistance | |
Category Variants Paths |
VHL mutant VHL inact mut VHL Y112N |
Transcript | NM_000551.4 |
gDNA | chr3:g.10142181T>A |
cDNA | c.334T>A |
Protein | p.Y112N |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |